US Stock MarketDetailed Quotes

BMRN Biomarin Pharmaceutical

Watchlist
  • 70.510
  • -0.510-0.72%
Close Mar 4 16:00 ET
  • 70.520
  • +0.010+0.01%
Pre 05:25 ET
13.45BMarket Cap31.90P/E (TTM)

About Biomarin Pharmaceutical Company

BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997, and is headquartered in San Rafael, CA.

Company Profile

SymbolBMRN
Company NameBiomarin Pharmaceutical
Listing DateJul 23, 1999
Issue Price13.00
Founded1997
CEOMr. Alexander Hardy
MarketNASDAQ
Employees3040
Fiscal Year Ends12-31
Address770 Lindaro Street
CitySan Rafael
ProvinceCalifornia
CountryUnited States of America
Zip Code94901
Phone1-415-506-6700
Websitehttp://www.biomarin.com

Company Executives

  • Name
  • Position
  • Salary
  • Alexander Hardy
  • Director, President and Chief Executive Officer
  • 17.88M
  • G. Eric Davis
  • Executive Vice President, Chief Legal Officer and Secretary
  • --
  • Charles Greg Guyer
  • Chief Technical Officer and Executive Vice President
  • 5.70M
  • Brian R. Mueller
  • Chief Financial Officer and Executive Vice President, Finance
  • 4.85M
  • Erin Burkhart
  • Group Vice President and Chief Accounting Officer
  • --
  • Dr. Greg Friberg
  • President, Chief Worldwide Research and Development Officer
  • --
  • Richard A. Meier
  • Chairman of the Board
  • 515.44K
  • Dr. Elaine J. Heron,PhD
  • Independent Director
  • 486.44K
  • Dr. Athena Countouriotis, M.D.
  • Independent Director
  • 213.38K
  • Robert J. Hombach
  • Independent Director
  • 486.94K
  • Mark Joseph Enyedy
  • Independent Director
  • 213.38K
  • Dr. Willard H. Dere, M.D.
  • Independent Director
  • 480.44K
  • Barbara W. Bodem
  • Independent Director
  • 213.38K
  • David E.I. Pyott, M.B.A.,M.D.
  • Independent Director
  • 470.44K
  • Timothy P. Walbert
  • Independent Director
  • --
  • Elizabeth McKee Anderson, M.B.A.
  • Independent Director
  • 480.44K
  • Dr. Maykin Ho, PhD
  • Independent Director
  • 473.94K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
LEETRO
430425
+29.97%
Geovis Insighter Technology
920116
+23.98%
Beijing Global Safety Technology
300523
+20.01%
4
Zhejiang JW Precision Machinery
300984
+20.00%
5
Wintao Communications
301139
+20.00%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Trump's comeback to the Office
Following Trump's Policies to Seek Investment Opportunities
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
TSLA earnings preview: Grab rewards by guessing the opening price!